Treatment with glecaprevir and pibrentasvir is safe and effective in italian patients with chronic hepatitis c aged 75 years or older: a multicenter study

HEPATOLOGY(2023)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要